These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15794907)

  • 1. In vitro and in vivo approaches to prevention and cure of T1D.
    Gottlieb PA
    Curr Diab Rep; 2005 Apr; 5(2):77-8. PubMed ID: 15794907
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin sensitizer prevents and ameliorates experimental type 1 diabetes.
    Valitsky M; Hoffman A; Unterman T; Bar-Tana J
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E672-E680. PubMed ID: 28270441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
    Zhang X; Xing S; Li M; Zhang L; Xie L; He W; Liu J; Chang S; Jiang F; Zhou P
    Metabolism; 2016 Sep; 65(9):1267-77. PubMed ID: 27506734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing agents for prevention or reversal of type 1 diabetes in rodents.
    Grant CW; Moran-Paul CM; Duclos SK; Guberski DL; Arreaza-Rubín G; Spain LM
    PLoS One; 2013; 8(8):e72989. PubMed ID: 24023664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention versus intervention of type 1 diabetes.
    Brooks-Worrell B; Palmer JP
    Clin Immunol; 2013 Dec; 149(3):332-8. PubMed ID: 23803322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice.
    Franke DD; Shirwan H
    Int Immunol; 2006 Mar; 18(3):453-8. PubMed ID: 16415097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of type I diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-DS) or 15-DS + cyclosporin A (CyA).
    Haberstroh J; Wilhelm T; Schulte-Mönting J; Schorlemmer HU; von Specht BU
    Immunol Lett; 1995 Dec; 48(2):117-21. PubMed ID: 8719109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S; Gross D; Weiss L
    Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
    [No Abstract]   [Full Text] [Related]  

  • 10. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
    Serreze DV; Niens M; Kulik J; DiLorenzo TP
    Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.
    Skyler JS; Ricordi C
    Diabetes; 2011 Jan; 60(1):1-8. PubMed ID: 21193733
    [No Abstract]   [Full Text] [Related]  

  • 13. [What has changed in the management of diabetes: medication and hygienic living].
    Rev Infirm; 2000 Apr; (59):23-4. PubMed ID: 11075168
    [No Abstract]   [Full Text] [Related]  

  • 14. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency.
    Xue S; Wasserfall CH; Parker M; Brusko TM; McGrail S; McGrail K; Moore M; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
    Ann N Y Acad Sci; 2008 Dec; 1150():152-6. PubMed ID: 19120286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of diosgenin-ibuprofen derivatives and their activities against insulin-dependent diabetes mellitus.
    Xin G; Wang Y; Guo X; Huang B; Du D; He S; Zhang R; Xing Z; Zhao H; Chen Q; Huang W; He Y
    Chem Pharm Bull (Tokyo); 2013; 61(5):532-8. PubMed ID: 23649196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus.
    Mann JI; De Leeuw I; Hermansen K; Karamanos B; Karlström B; Katsilambros N; Riccardi G; Rivellese AA; Rizkalla S; Slama G; Toeller M; Uusitupa M; Vessby B;
    Nutr Metab Cardiovasc Dis; 2004 Dec; 14(6):373-94. PubMed ID: 15853122
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
    Stosić-Grujicić S; Cvjetićanin T; Stojanović I
    Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes.
    Beales PE; Pozzilli P
    Diabetes Metab Res Rev; 2002; 18(2):114-7. PubMed ID: 11994902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.
    Maki T; Gottschalk R; Ogawa N; Monaco AP
    Transplantation; 2005 May; 79(9):1051-5. PubMed ID: 15880042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.